Photo courtesy: The Indian Express
New Delhi: Eminent Indian virologist, Gagandeep Kang is skeptical about the Centre’s claim that it will get over 2 billion doses of vaccine from August to December. The production capacity of vaccine makers such as Serum Institute and Bharat Biotech is yet to ramp up, she said.
There is also no sufficient data to show the efficacy of Bharat Biotech’s nasal vaccine and Zydus Cadila’s DNA vaccine, she told Moneycontrol in an exclusive interview.
“I take the projections with a grain of salt. If you remember, last year, we were told that, by December, Serum Institute would produce 100 million doses of vaccine and Bharat Biotech in tens of millions of doses. There was going to be a large stockpile that was available with them. As we have found, that is not the case,” Kang told Moneycontrol.
It may be recalled that some states have floated global tenders for procuring a total of 121 million vaccine doses.
New Delhi: The prospect of an all-out war with Iran intensified as Israel launched a major…
Bhubaneswar: As Bharatiya Janata Party (BJP) completed 100 days after coming to power in Odisha,…
Mumbai: Remember Vijayta Pandit? Yes, the younger sister of Sulakshana Pandit who burst into Bollywood…
Bhubaneswar: As the alleged custodial assault of an Army officer and his fiancée at Bharatpur…
Hyderabad: The row over Tirupati Prasadam is set to escalate after a lab report has…
Kolkata: Chief Justice of India (CJI) D Y Chandrachud observed during Tuesday’s hearing in the…
Rayagada: A large number of irate people armed with traditional weapons laid siege to Kashipur…
Bhubaneswar: Congress workers and leaders staged a demonstration in Bhubaneswar on Thursday protesting ‘derogatory’ statements…